STMN4 | 35610288 | Prognostic | Unknown | Tissue | Colorectal cancer | Identification of gene signatures for COAD using feature selection and Bayesian |
STMN4 | 35610288 | Prognostic | Unknown | Tissue | Colon Cancer | Identification of gene signatures for COAD using feature selection and Bayesian |
CLCA4 | 36991484 | Prognostic | Downregulated | Other | Colorectal cancer | Bioinformatics screening of colorectal-cancer causing molecular signatures |
CLCA4 | 36532007 | Prognostic | Unknown | Tissue | Colorectal cancer | A novel enterocyte-related 4-gene signature for predicting prognosis in colon |
CLCA4 | 35693937 | Prognostic | Downregulated | Tissue | Colorectal cancer | Identification of Hub Genes in Colorectal Adenocarcinoma by Integrated |
CLCA4 | 35300114 | Prognostic | Unknown | Tissue | Colorectal cancer | Identification of Down-Regulated ADH1C is Associated With Poor Prognosis in |
CLCA4 | 36532007 | Prognostic | Unknown | Tissue | Colon Cancer | A novel enterocyte-related 4-gene signature for predicting prognosis in colon |
GUCA2B | 38767504 | Prognostic | Downregulated | Tissue | Colorectal cancer | Gene Co-Expression and miRNA Regulation: A Path to Early Intervention in |
GUCA2B | 36991484 | Prognostic | Downregulated | Other | Colorectal cancer | Bioinformatics screening of colorectal-cancer causing molecular signatures |
GUCA2B | 36660654 | Prognostic | Unknown | Tissue | Colorectal cancer | DNAH7 mutations benefit colorectal cancer patients receiving immune checkpoint |
GUCA2B | 34390411 | Prognostic | Unknown | Other | Colorectal cancer | Employing bioinformatics analysis to identify hub genes and microRNAs involved in |
GUCA2B | 33919332 | Prognostic | Downregulated | Other | Colorectal cancer | Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: |
GUCA2B | 33919332 | Prognostic | Downregulated | Other | Colon Cancer | Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: |
NFE2L3 | 30654001 | Prognostic | Unknown | Other | Colorectal cancer | Identification of biomarkers associated with diagnosis and prognosis of |
NFE2L3 | 31186640 | Prognostic | Upregulated | Other | Colon Cancer | Identification of Transcriptional Signatures of Colon Tumor Stroma by a |
NFE2L3 | 35846126 | Prognostic | Upregulated | Other | Cancer Related Liver | Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of |
CDH3 | 38064156 | Prognostic | Downregulated | Tissue | Colorectal cancer | Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases |
CDH3 | 38665548 | Prognostic | Unknown | Other | Colorectal cancer | Relationship between 233 colorectal cancer risk loci and survival in 1926 |
CDH3 | 35114976 | Prognostic | Unknown | Urine | Colorectal cancer | Uncovering potential genes in colorectal cancer based on integrated and DNA |
CDH3 | 29142905 | Prognostic | Unknown | Tissue | Colon Cancer | P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a |
GLP2R | 38312843 | Prognostic | Unknown | Other | Colorectal cancer | Development and verification of a combined immune- and cancer-associated |
GLP2R | 37076536 | Prognostic | Downregulated | Tissue | Colorectal cancer | Prognostic model development for classification of colorectal adenocarcinoma by |
GLP2R | 32788867 | Prognostic | Unknown | Other | Colorectal cancer | A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. |
GLP2R | 38312843 | Prognostic | Unknown | Other | Colon Cancer | Development and verification of a combined immune- and cancer-associated |
GLP2R | 32788867 | Prognostic | Unknown | Other | Colon Cancer | A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. |
TRIP13 | 35114976 | Prognostic | Unknown | Urine | Colorectal cancer | Uncovering potential genes in colorectal cancer based on integrated and DNA |
TRIP13 | 36785674 | Prognostic | Unknown | Other | Cancer Related Liver | Identification of a Five Immune Term Signature for Prognosis and Therapy Options |
TRIP13 | 32382578 | Prognostic | Unknown | Other | Cancer Related Liver | Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and |
MMP11 | 38627864 | Prognostic | Unknown | Tissue | Colorectal cancer | Relationship of FDG PET/CT imaging features with tumor immune microenvironment |
MMP11 | 36105798 | Prognostic | Unknown | Tissue | Colorectal cancer | Systematic identification of cancer-associated-fibroblast-derived genes in |
MMP11 | 34804973 | Prognostic | Upregulated | Other | Colorectal cancer | Comprehensive Analysis of the Expression and Prognosis for MMPs in Human |
MMP11 | 27002762 | Prognostic | Unknown | Blood | Colon Cancer | Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer |
MMP11 | 22927434 | Prognostic | Unknown | Tissue | Colon Cancer | Extra- and intracellular imaging of human matrix metalloprotease 11 (hMMP-11) |
MMP11 | 36169759 | Prognostic | Unknown | Tissue | Cancer Related Liver | Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with |
MMP11 | 36044785 | Prognostic | Unknown | Other | Cancer Related Liver | Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic |
SEC14L2 | 34141458 | Prognostic | Unknown | Other | Cancer Related Liver | Construction of a Myc-associated ceRNA network reveals a prognostic signature in |
SLCO4A1 | 37124063 | Prognostic | Unknown | Tissue | Colorectal cancer | Prognostic Biomarker SLCO4A1 Is Correlated with Tumor Immune Infiltration in |
SLCO4A1 | 36032659 | Prognostic | Unknown | Other | Colorectal cancer | Identification and Validation of an m6A-Related LncRNA Signature to Predict |
SLCO4A1 | 35039060 | Prognostic | Upregulated | Tissue | Colorectal cancer | SLCO4A1-AS1 promotes colorectal tumourigenesis by regulating Cdk2/c-Myc |
SLCO4A1 | 37124063 | Prognostic | Unknown | Tissue | Colon Cancer | Prognostic Biomarker SLCO4A1 Is Correlated with Tumor Immune Infiltration in |
SLCO4A1 | 35433689 | Prognostic | Unknown | Other | Cancer Related Liver | Integrated Analysis of Genes Associated With Immune Microenvironment and Distant |
TRIB3 | 32457797 | Prognostic | Unknown | Other | Colon Cancer | Immune-Related Prognostic Model in Colon Cancer: A Gene Expression-Based Study. |
TRIB3 | 31448228 | Prognostic | Unknown | Other | Colon Cancer | Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in |
TRIB3 | 32716348 | Prognostic | Upregulated | Tissue | Cancer Related Liver | TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis. |
SGCG | 31612869 | Prognostic | Unknown | Other | Colorectal cancer | Association of a novel seven-gene expression signature with the disease prognosis |
SGCG | 31612869 | Prognostic | Unknown | Other | Colon Cancer | Association of a novel seven-gene expression signature with the disease prognosis |
CEMIP | 36991484 | Prognostic | Downregulated | Other | Colorectal cancer | Bioinformatics screening of colorectal-cancer causing molecular signatures |
CEMIP | 34680448 | Prognostic | Upregulated | Cell lines | Colorectal cancer | Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in |
CEMIP | 34680448 | Prognostic | Upregulated | Cell lines | Colon Cancer | Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in |
CEMIP | 26437221 | Prognostic | Unknown | Other | Colon Cancer | Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor |
CEMIP | 33327261 | Prognostic | Upregulated | Tissue | Cancer Related Liver | Co-expression of KIAA1199 and hypoxia-inducible factor 1alpha is a biomarker for an |
STMN2 | 37719786 | Prognostic | Unknown | Tissue | Colorectal cancer | An Analysis of the Gene Expression Associated with Lymph Node Metastasis in |
STMN2 | 33085517 | Prognostic | Unknown | Tissue | Colorectal cancer | Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for |
STMN2 | 37719786 | Prognostic | Unknown | Tissue | Colon Cancer | An Analysis of the Gene Expression Associated with Lymph Node Metastasis in |
STMN2 | 33085517 | Prognostic | Unknown | Tissue | Colon Cancer | Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for |
GRIN2D | 35646712 | Prognostic | Unknown | Other | Cancer Related Liver | Reclassification of Hepatocellular Cancer With Neural-Related Genes. |
MSX2 | 28286778 | Prognostic | Unknown | Tissue | Colorectal cancer | Prognostic Relevance and Function of MSX2 in Colorectal Cancer. |
INHBA | 38735606 | Prognostic | Unknown | Tissue | Colorectal cancer | Discovery of PELATON links to the INHBA gene in the TGF-beta pathway in colorectal |
INHBA | 37539967 | Prognostic | Upregulated | Tissue | Colorectal cancer | Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1(+) |
INHBA | 37377935 | Prognostic | Unknown | Other | Colorectal cancer | Constructing a cancer stem cell related prognostic model for predicting immune |
INHBA | 37370046 | Prognostic | Unknown | Other | Colorectal cancer | A novel nomogram based on cell cycle-related genes for predicting overall |
INHBA | 33140821 | Prognostic | Unknown | Other | Colon Cancer | Identification prognosis-associated immune genes in colon adenocarcinoma. |
INHBA | 32788867 | Prognostic | Unknown | Other | Colon Cancer | A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. |
PYY | 36191342 | Prognostic | Unknown | Other | Colorectal cancer | Clinicopathologic Impact of Peptide Hormonal Expression in Rectal Neuroendocrine |
PYY | 35490318 | Prognostic | Unknown | Other | Colorectal cancer | Transcriptomic Signatures in Colorectal Cancer Progression. |
GLTP | 32640984 | Prognostic | Unknown | Tissue | Colorectal cancer | Molecular docking and machine learning analysis of Abemaciclib in colon cancer. |
GLTP | 32640984 | Prognostic | Unknown | Tissue | Colon Cancer | Molecular docking and machine learning analysis of Abemaciclib in colon cancer. |
PDX1 | 35260172 | Prognostic | Unknown | Blood | Colorectal cancer | An organoid model of colorectal circulating tumor cells with stem cell features, |
PDX1 | 35169223 | Prognostic | Unknown | Tissue | Colorectal cancer | Hypermethylation of PDX1, EN2, and MSX1 predicts the prognosis of colorectal |
PDX1 | 30999858 | Prognostic | Unknown | Tissue | Colorectal cancer | Walking pathways with positive feedback loops reveal DNA methylation biomarkers |
PDX1 | 24023782 | Prognostic | Unknown | Other | Colorectal cancer | Cancer stem cell gene profile as predictor of relapse in high risk stage II and |
PDX1 | 24023782 | Prognostic | Unknown | Other | Colon Cancer | Cancer stem cell gene profile as predictor of relapse in high risk stage II and |
PDX1 | 36714595 | Prognostic | Unknown | Other | Cancer Related Liver | Overweight/obesity-related transcriptomic signature as a correlate of clinical |
BEST4 | 35194111 | Prognostic | Unknown | Other | Colorectal cancer | Weighted correlation network analysis revealed novel long non-coding RNAs for |
BEST4 | 35114976 | Prognostic | Unknown | Urine | Colorectal cancer | Uncovering potential genes in colorectal cancer based on integrated and DNA |
BEST4 | 31024853 | Prognostic | Unknown | Tissue | Colorectal cancer | Prognosis Prediction of Colorectal Cancer Using Gene Expression Profiles. |
RSPO2 | 37692504 | Prognostic | Unknown | Other | Colorectal cancer | RSPO2 as Wnt signaling enabler: Important roles in cancer development and |
RSPO2 | 36255654 | Prognostic | Unknown | Tissue | Colorectal cancer | Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple |
RSPO2 | 37692504 | Prognostic | Unknown | Other | Colon Cancer | RSPO2 as Wnt signaling enabler: Important roles in cancer development and |
RSPO2 | 36255654 | Prognostic | Unknown | Tissue | Colon Cancer | Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple |
FAM135B | 35610288 | Prognostic | Unknown | Tissue | Colorectal cancer | Identification of gene signatures for COAD using feature selection and Bayesian |
FAM135B | 35610288 | Prognostic | Unknown | Tissue | Colon Cancer | Identification of gene signatures for COAD using feature selection and Bayesian |
BMP3 | 37936149 | Prognostic | Unknown | Other | Colorectal cancer | Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic |
BMP3 | 35307512 | Prognostic | Unknown | Tissue | Colorectal cancer | DNA methylation-based diagnostic, prognostic, and predictive biomarkers in |
LRP8 | 35663062 | Prognostic | Upregulated | Tissue | Colorectal cancer | Reduced serum high-density lipoprotein cholesterol levels and aberrantly |
IL6R | 36685857 | Prognostic | Unknown | Blood | Colorectal cancer | Transcriptomic data analysis coupled with copy number aberrations reveals a |
CLDN1 | 38540693 | Prognostic | Upregulated | Other | Colorectal cancer | The Expression of the Claudin Family of Proteins in Colorectal Cancer. |
CLDN1 | 36991484 | Prognostic | Downregulated | Other | Colorectal cancer | Bioinformatics screening of colorectal-cancer causing molecular signatures |
CLDN1 | 35281827 | Prognostic | Unknown | Tissue | Colorectal cancer | Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression |
CLDN1 | 38540693 | Prognostic | Upregulated | Other | Colon Cancer | The Expression of the Claudin Family of Proteins in Colorectal Cancer. |
CLDN1 | 33572952 | Prognostic | Unknown | Tissue | Colon Cancer | The Importance of Sex in the Discovery of Colorectal Cancer Prognostic |
CLDN1 | 38185042 | Prognostic | Unknown | Other | Cancer Related Liver | Claudins and hepatocellular carcinoma. |
CLDN1 | 32034780 | Prognostic | Unknown | Tissue | Cancer Related Liver | Characterisation of endogenous Claudin-1 expression, motility and susceptibility |
CLDN1 | 31769164 | Prognostic | Unknown | Other | Cancer Related Liver | Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma |
ESM1 | 36890467 | Prognostic | Unknown | Tissue | Colorectal cancer | Development of an immune-related gene prognostic risk model and identification of |
ESM1 | 36518242 | Prognostic | Unknown | Tissue | Colorectal cancer | Exploration and validation of a combined immune and metabolism gene signature for |
ESM1 | 33572952 | Prognostic | Unknown | Tissue | Colorectal cancer | The Importance of Sex in the Discovery of Colorectal Cancer Prognostic |
ESM1 | 33330631 | Prognostic | Unknown | Tissue | Colorectal cancer | Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes. |
ESM1 | 32788867 | Prognostic | Unknown | Other | Colorectal cancer | A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. |
ESM1 | 32564470 | Prognostic | Unknown | Tissue | Colorectal cancer | A novel prognostic signature of immune-related genes for patients with colorectal |
ESM1 | 36890467 | Prognostic | Unknown | Tissue | Colon Cancer | Development of an immune-related gene prognostic risk model and identification of |
ESM1 | 33572952 | Prognostic | Unknown | Tissue | Colon Cancer | The Importance of Sex in the Discovery of Colorectal Cancer Prognostic |
ESM1 | 33330631 | Prognostic | Unknown | Tissue | Colon Cancer | Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes. |
ESM1 | 32788867 | Prognostic | Unknown | Other | Colon Cancer | A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. |
ESM1 | 22948784 | Prognostic | Unknown | Tissue | Colon Cancer | Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible |
ESM1 | 36518242 | Prognostic | Unknown | Tissue | Cancer Related Liver | Exploration and validation of a combined immune and metabolism gene signature for |
ESM1 | 31358545 | Prognostic | Unknown | Other | Cancer Related Liver | ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma. |
ESM1 | 20383661 | Prognostic | Unknown | Tissue | Cancer Related Liver | Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer. |
FOXQ1 | 36118871 | Prognostic | Unknown | Tissue | Colon Cancer | Pan-cancer analysis of forkhead box Q1 as a potential prognostic and |
FOXQ1 | 34680448 | Prognostic | Upregulated | Cell lines | Colon Cancer | Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in |
FOXQ1 | 36958694 | Prognostic | Upregulated | Tissue | Cancer Related Liver | m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic |
FOXQ1 | 36118871 | Prognostic | Unknown | Tissue | Cancer Related Liver | Pan-cancer analysis of forkhead box Q1 as a potential prognostic and |
FOXQ1 | 25704764 | Prognostic | Unknown | Tissue | Cancer Related Liver | Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis |
VWA2 | 33572952 | Prognostic | Unknown | Tissue | Colorectal cancer | The Importance of Sex in the Discovery of Colorectal Cancer Prognostic |
VWA2 | 33572952 | Prognostic | Unknown | Tissue | Colon Cancer | The Importance of Sex in the Discovery of Colorectal Cancer Prognostic |
KRT80 | 34680448 | Prognostic | Upregulated | Cell lines | Colorectal cancer | Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in |
KRT80 | 30262880 | Prognostic | Unknown | Other | Colorectal cancer | Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting |
KRT80 | 34680448 | Prognostic | Upregulated | Cell lines | Colon Cancer | Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in |
SCARA5 | 35755171 | Prognostic | Unknown | Tissue | Cancer Related Liver | Highly Expressing SCARA5 Promotes Proliferation and Migration of Esophageal |
GFRA2 | 35114976 | Prognostic | Unknown | Urine | Colorectal cancer | Uncovering potential genes in colorectal cancer based on integrated and DNA |
GFRA2 | 35646712 | Prognostic | Unknown | Other | Cancer Related Liver | Reclassification of Hepatocellular Cancer With Neural-Related Genes. |
CA7 | 37895185 | Prognostic | Unknown | Other | Colorectal cancer | Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early |
CA7 | 35114976 | Prognostic | Unknown | Urine | Colorectal cancer | Uncovering potential genes in colorectal cancer based on integrated and DNA |
CA7 | 34153790 | Prognostic | Unknown | Other | Colorectal cancer | Machine learning and network-based models to identify genetic risk factors to the |
CA7 | 29788743 | Prognostic | Unknown | Plasma | Colorectal cancer | Novel insights into transcriptional dysregulation in colorectal cancer. |
CA7 | 28229027 | Prognostic | Unknown | Tissue | Colorectal cancer | Risk analysis of colorectal cancer incidence by gene expression analysis. |
CA7 | 25885898 | Prognostic | Downregulated | Tissue | Colorectal cancer | Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma. |
CA7 | 37895185 | Prognostic | Unknown | Other | Colon Cancer | Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early |
CA7 | 28229027 | Prognostic | Unknown | Tissue | Colon Cancer | Risk analysis of colorectal cancer incidence by gene expression analysis. |
CA7 | 25885898 | Prognostic | Downregulated | Tissue | Colon Cancer | Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma. |
CST1 | 34335931 | Prognostic | Unknown | Tissue | Colorectal cancer | Identification of Cysteine Protease Inhibitor CST2 as a Potential Biomarker for |
CST1 | 31115549 | Prognostic | Unknown | Tissue | Colorectal cancer | Investigation of the clinical significance and prospective molecular mechanisms |
CST1 | 29383149 | Prognostic | Upregulated | Other | Colorectal cancer | Prognostic significance of cystatin SN associated nomograms in patients with |
CST1 | 31115549 | Prognostic | Unknown | Tissue | Cancer Related Liver | Investigation of the clinical significance and prospective molecular mechanisms |
VSTM2A | 37076536 | Prognostic | Downregulated | Tissue | Colorectal cancer | Prognostic model development for classification of colorectal adenocarcinoma by |
VSTM2A | 31588233 | Prognostic | Downregulated | Tissue | Colorectal cancer | VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6. |
VSTM2A | 31588233 | Prognostic | Downregulated | Tissue | Colon Cancer | VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6. |
ETV4 | 37248886 | Prognostic | Unknown | Tissue | Colorectal cancer | Down-regulated MiRNA 29-b as a diagnostic marker in colorectal cancer and its |
ETV4 | 35860243 | Prognostic | Unknown | Other | Colorectal cancer | ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis |
ETV4 | 34753916 | Prognostic | Unknown | Other | Colorectal cancer | Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting |
ETV4 | 34680448 | Prognostic | Upregulated | Cell lines | Colorectal cancer | Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in |
ETV4 | 37248886 | Prognostic | Unknown | Tissue | Colon Cancer | Down-regulated MiRNA 29-b as a diagnostic marker in colorectal cancer and its |
ETV4 | 34753916 | Prognostic | Unknown | Other | Colon Cancer | Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting |
ETV4 | 34680448 | Prognostic | Upregulated | Cell lines | Colon Cancer | Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in |
ETV4 | 37986299 | Prognostic | Unknown | Tissue | Cancer Related Liver | Development and validation of multi-omic prognostic signature of anoikis-related |
ETV4 | 36907560 | Prognostic | Upregulated | Other | Cancer Related Liver | FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma |
TMIGD1 | 35481970 | Prognostic | Downregulated | Tissue | Colorectal cancer | The Role of TMIGD1 as a Tumor Suppressor in Colorectal Cancer. |
OTOP3 | 35587572 | Prognostic | Unknown | Tissue | Colorectal cancer | Prognosis prediction of stage IV colorectal cancer patients by mRNA |
OTOP3 | 31612869 | Prognostic | Unknown | Other | Colorectal cancer | Association of a novel seven-gene expression signature with the disease prognosis |
OTOP3 | 35587572 | Prognostic | Unknown | Tissue | Colon Cancer | Prognosis prediction of stage IV colorectal cancer patients by mRNA |
OTOP3 | 31612869 | Prognostic | Unknown | Other | Colon Cancer | Association of a novel seven-gene expression signature with the disease prognosis |
OTOP3 | 35587572 | Prognostic | Unknown | Tissue | Cancer Related Liver | Prognosis prediction of stage IV colorectal cancer patients by mRNA |
SFTA2 | 38443703 | Prognostic | Unknown | Other | Colorectal cancer | Identification and validation of a novel six-gene signature based on mucinous |
SFTA2 | 37377935 | Prognostic | Unknown | Other | Colorectal cancer | Constructing a cancer stem cell related prognostic model for predicting immune |
SFTA2 | 35587572 | Prognostic | Unknown | Tissue | Colorectal cancer | Prognosis prediction of stage IV colorectal cancer patients by mRNA |
SFTA2 | 32351322 | Prognostic | Unknown | Other | Colorectal cancer | Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal |
SFTA2 | 29653552 | Prognostic | Unknown | Tissue | Colorectal cancer | Independent prognostic genes and mechanism investigation for colon cancer. |
SFTA2 | 35587572 | Prognostic | Unknown | Tissue | Colon Cancer | Prognosis prediction of stage IV colorectal cancer patients by mRNA |
SFTA2 | 29653552 | Prognostic | Unknown | Tissue | Colon Cancer | Independent prognostic genes and mechanism investigation for colon cancer. |
SFTA2 | 35587572 | Prognostic | Unknown | Tissue | Cancer Related Liver | Prognosis prediction of stage IV colorectal cancer patients by mRNA |
S100A2 | 37476187 | Prognostic | Unknown | Tissue | Colorectal cancer | Protein expression of S100A2 reveals it association with patient prognosis and |
S100A2 | 33294444 | Prognostic | Unknown | Tissue | Colorectal cancer | An Integrated Bioinformatic Analysis of the S100 Gene Family for the Prognosis of |
S100A2 | 27935967 | Prognostic | Upregulated | Other | Colorectal cancer | Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression |
S100A2 | 26783118 | Prognostic | Upregulated | Tissue | Colorectal cancer | Overexpression of the S100A2 protein as a prognostic marker for patients with |
S100A2 | 33294444 | Prognostic | Unknown | Tissue | Colon Cancer | An Integrated Bioinformatic Analysis of the S100 Gene Family for the Prognosis of |
S100A2 | 27935967 | Prognostic | Upregulated | Other | Colon Cancer | Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression |
S100A2 | 33815482 | Prognostic | Unknown | Tissue | Cancer Related Liver | Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration |
S100A2 | 33546025 | Prognostic | Unknown | Other | Cancer Related Liver | S100 family members: potential therapeutic target in patients with hepatocellular |
BLACAT1 | 33180447 | Prognostic | Upregulated | Other | Colorectal cancer | Prognostic and Clinicopathological Significance of Long Non-Coding RNA BLACAT1 in |
BLACAT1 | 31558855 | Prognostic | Unknown | Tissue | Colorectal cancer | Diagnostic and prognostic potential of tissue and circulating long non-coding |
BLACAT1 | 28277544 | Prognostic | Unknown | Other | Colorectal cancer | Long noncoding RNA BLACAT1 indicates a poor prognosis of colorectal cancer and |
BLACAT1 | 35837189 | Prognostic | Unknown | Other | Colon Cancer | Expression characteristics of long non-coding RNA in colon adenocarcinoma and its |
BLACAT1 | 31558855 | Prognostic | Unknown | Tissue | Colon Cancer | Diagnostic and prognostic potential of tissue and circulating long non-coding |
BLACAT1 | 28277544 | Prognostic | Unknown | Other | Colon Cancer | Long noncoding RNA BLACAT1 indicates a poor prognosis of colorectal cancer and |
IBSP | 31709184 | Prognostic | Upregulated | Other | Esophageal cancer | Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With |
IBSP | 31709184 | Prognostic | Upregulated | Other | Esophageal Squamous Cell Carcinoma | Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With |
IBSP | 31709184 | Prognostic | Upregulated | Other | Cancer Related Esophageal | Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With |
HOXC8 | 36924407 | Prognostic | Unknown | Other | Esophageal cancer | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC8 | 33960364 | Prognostic | Unknown | Plasma | Esophageal cancer | Integrated analysis of ceRNA network and tumor-infiltrating immune cells in |
HOXC8 | 30844117 | Prognostic | Upregulated | Tissue | Esophageal cancer | Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal |
HOXC8 | 24525058 | Prognostic | Unknown | Other | Esophageal cancer | The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous |
HOXC8 | 30844117 | Prognostic | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal |
HOXC8 | 24525058 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous |
HOXC8 | 36924407 | Prognostic | Unknown | Other | Cancer Related Esophageal | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC8 | 33960364 | Prognostic | Unknown | Plasma | Cancer Related Esophageal | Integrated analysis of ceRNA network and tumor-infiltrating immune cells in |
HOXC8 | 30844117 | Prognostic | Upregulated | Tissue | Cancer Related Esophageal | Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal |
TRIP13 | 31064720 | Prognostic | Upregulated | Tissue | Esophageal cancer | TRIP13 upregulation is correlated with poor prognosis and tumor progression in |
TRIP13 | 31064720 | Prognostic | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | TRIP13 upregulation is correlated with poor prognosis and tumor progression in |
TRIP13 | 31064720 | Prognostic | Upregulated | Tissue | Cancer Related Esophageal | TRIP13 upregulation is correlated with poor prognosis and tumor progression in |
BIRC5 | 37416747 | Prognostic | Unknown | Other | Esophageal cancer | Identification of hub genes and microRNAs with prognostic values in esophageal |
BIRC5 | 37312528 | Prognostic | Unknown | Other | Esophageal cancer | NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with |
BIRC5 | 35600392 | Prognostic | Downregulated | Other | Esophageal cancer | SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor |
BIRC5 | 32998713 | Prognostic | Downregulated | Tissue | Esophageal cancer | Profiles of autophagy-related genes in esophageal adenocarcinoma. |
BIRC5 | 32998713 | Prognostic | Downregulated | Tissue | Esophageal Adenocarcinoma | Profiles of autophagy-related genes in esophageal adenocarcinoma. |
BIRC5 | 26315108 | Prognostic | Unknown | Blood | Esophageal Adenocarcinoma | Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced |
BIRC5 | 25869644 | Prognostic | Unknown | Tissue | Esophageal Adenocarcinoma | Molecular markers predicting lymph node metastasis in early esophageal cancer. |
BIRC5 | 24223792 | Prognostic | Unknown | Tissue | Esophageal Adenocarcinoma | Prognostic value and targeted inhibition of survivin expression in esophageal |
BIRC5 | 37312528 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with |
BIRC5 | 31789057 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | The expression and prognostic value of SOX2, beta-catenin and survivin in esophageal |
BIRC5 | 31165868 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of |
BIRC5 | 37416747 | Prognostic | Unknown | Other | Cancer Related Esophageal | Identification of hub genes and microRNAs with prognostic values in esophageal |
BIRC5 | 37312528 | Prognostic | Unknown | Other | Cancer Related Esophageal | NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with |
BIRC5 | 35600392 | Prognostic | Downregulated | Other | Cancer Related Esophageal | SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor |
BIRC5 | 32998713 | Prognostic | Downregulated | Tissue | Cancer Related Esophageal | Profiles of autophagy-related genes in esophageal adenocarcinoma. |
BIRC5 | 31789057 | Prognostic | Unknown | Other | Cancer Related Esophageal | The expression and prognostic value of SOX2, beta-catenin and survivin in esophageal |
HNRNPC | 36733344 | Prognostic | Unknown | Tissue | Esophageal cancer | Identification of m6a-related signature genes in esophageal squamous cell |
HNRNPC | 35614994 | Prognostic | Unknown | Tissue | Esophageal cancer | Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma |
HNRNPC | 34395102 | Prognostic | Unknown | Tissue | Esophageal cancer | Network analysis of miRNA targeting m6A-related genes in patients with esophageal |
HNRNPC | 34054840 | Prognostic | Unknown | Tissue | Esophageal cancer | Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA |
HNRNPC | 33563334 | Prognostic | Upregulated | Tissue | Esophageal cancer | Alterations of RNA splicing patterns in esophagus squamous cell carcinoma. |
HNRNPC | 32753956 | Prognostic | Upregulated | Tissue | Esophageal cancer | Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic |
HNRNPC | 36733344 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Identification of m6a-related signature genes in esophageal squamous cell |
HNRNPC | 34054840 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA |
HNRNPC | 33563334 | Prognostic | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | Alterations of RNA splicing patterns in esophagus squamous cell carcinoma. |
HNRNPC | 36733344 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | Identification of m6a-related signature genes in esophageal squamous cell |
HNRNPC | 34395102 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | Network analysis of miRNA targeting m6A-related genes in patients with esophageal |
HNRNPC | 34054840 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA |
HNRNPC | 33563334 | Prognostic | Upregulated | Tissue | Cancer Related Esophageal | Alterations of RNA splicing patterns in esophagus squamous cell carcinoma. |
IL11 | 37428781 | Prognostic | Upregulated | Tissue | Esophageal cancer | The possible molecular mechanism underlying the involvement of the variable shear |
IL11 | 32869505 | Prognostic | Unknown | Other | Esophageal cancer | Multivariate gene expression-based survival predictor model in esophageal |
IL11 | 32869505 | Prognostic | Unknown | Other | Esophageal Adenocarcinoma | Multivariate gene expression-based survival predictor model in esophageal |
IL11 | 37428781 | Prognostic | Upregulated | Tissue | Cancer Related Esophageal | The possible molecular mechanism underlying the involvement of the variable shear |
MMP11 | 34404882 | Prognostic | Unknown | Tissue | Esophageal cancer | Integrated bioinformatics analysis of differentially expressed genes and immune |
MMP11 | 23341893 | Prognostic | Unknown | Other | Esophageal cancer | SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell |
MMP11 | 15557792 | Prognostic | Unknown | Tissue | Esophageal cancer | Prognostic significance of stromelysin-3 and tissue inhibitor of matrix |
MMP11 | 15069682 | Prognostic | Unknown | Other | Esophageal cancer | Differential expression of MMP and uPA systems and prognostic relevance of their |
MMP11 | 34404882 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Integrated bioinformatics analysis of differentially expressed genes and immune |
MMP11 | 23341893 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell |
MMP11 | 15557792 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Prognostic significance of stromelysin-3 and tissue inhibitor of matrix |
MMP11 | 15069682 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | Differential expression of MMP and uPA systems and prognostic relevance of their |
MMP11 | 34404882 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | Integrated bioinformatics analysis of differentially expressed genes and immune |
MMP11 | 23341893 | Prognostic | Unknown | Other | Cancer Related Esophageal | SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell |
MMP11 | 15069682 | Prognostic | Unknown | Other | Cancer Related Esophageal | Differential expression of MMP and uPA systems and prognostic relevance of their |
CDC25B | 31748958 | Prognostic | Unknown | Other | Esophageal cancer | The prognostic role of FZD6 in esophageal squamous cell carcinoma patients. |
CDC25B | 29188501 | Prognostic | Unknown | Other | Esophageal cancer | Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant |
CDC25B | 20813067 | Prognostic | Unknown | Blood | Esophageal cancer | Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced |
CDC25B | 31748958 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | The prognostic role of FZD6 in esophageal squamous cell carcinoma patients. |
CDC25B | 29188501 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant |
CDC25B | 20813067 | Prognostic | Unknown | Blood | Esophageal Squamous Cell Carcinoma | Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced |
CDC25B | 31748958 | Prognostic | Unknown | Other | Cancer Related Esophageal | The prognostic role of FZD6 in esophageal squamous cell carcinoma patients. |
CDC25B | 20813067 | Prognostic | Unknown | Blood | Cancer Related Esophageal | Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced |
DDX39A | 34568328 | Prognostic | Unknown | Tissue | Esophageal cancer | RNA-Binding Proteins CLK1 and POP7 as Biomarkers for Diagnosis and Prognosis of |
DDX39A | 34568328 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | RNA-Binding Proteins CLK1 and POP7 as Biomarkers for Diagnosis and Prognosis of |
DDX39A | 34568328 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | RNA-Binding Proteins CLK1 and POP7 as Biomarkers for Diagnosis and Prognosis of |
HOXC11 | 36924407 | Prognostic | Unknown | Other | Esophageal cancer | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC11 | 36924407 | Prognostic | Unknown | Other | Cancer Related Esophageal | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
RFC3 | 22328562 | Prognostic | Unknown | Tissue | Esophageal cancer | Integrative genomics identified RFC3 as an amplified candidate oncogene in |
RFC3 | 22328562 | Prognostic | Unknown | Tissue | Esophageal Adenocarcinoma | Integrative genomics identified RFC3 as an amplified candidate oncogene in |
NRM | 35030629 | Prognostic | Unknown | Blood | Esophageal cancer | Regenerating islet-derived protein 3-alpha is a prognostic biomarker for |
NRM | 23395601 | Prognostic | Unknown | Blood | Esophageal cancer | Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] |
MMP3 | 36991467 | Prognostic | Unknown | Tissue | Esophageal cancer | FBXW7 loss of function promotes esophageal squamous cell carcinoma progression |
MMP3 | 34404882 | Prognostic | Unknown | Tissue | Esophageal cancer | Integrated bioinformatics analysis of differentially expressed genes and immune |
MMP3 | 33243974 | Prognostic | Unknown | Tissue | Esophageal cancer | Identification of miR-515-3p and its targets, vimentin and MMP3, as a key |
MMP3 | 36991467 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | FBXW7 loss of function promotes esophageal squamous cell carcinoma progression |
MMP3 | 34404882 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Integrated bioinformatics analysis of differentially expressed genes and immune |
MMP3 | 33243974 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Identification of miR-515-3p and its targets, vimentin and MMP3, as a key |
MMP3 | 31793228 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Integrated analysis of genomic and transcriptomic profiles identified a |
MMP3 | 36991467 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | FBXW7 loss of function promotes esophageal squamous cell carcinoma progression |
MMP3 | 34404882 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | Integrated bioinformatics analysis of differentially expressed genes and immune |
MMP3 | 33243974 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | Identification of miR-515-3p and its targets, vimentin and MMP3, as a key |
MMP3 | 30602372 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | PRAME promotes epithelial-to-mesenchymal transition in triple negative breast |
TDO2 | 34589400 | Prognostic | Unknown | Tissue | Esophageal cancer | Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote |
TDO2 | 34589400 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote |
ESM1 | 35937390 | Prognostic | Unknown | Tissue | Esophageal cancer | ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal |
ESM1 | 35071405 | Prognostic | Unknown | Other | Esophageal cancer | Identification of key genes associated with esophageal adenocarcinoma based on |
ESM1 | 33175267 | Prognostic | Unknown | Other | Esophageal cancer | Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer. |
ESM1 | 35071405 | Prognostic | Unknown | Other | Esophageal Adenocarcinoma | Identification of key genes associated with esophageal adenocarcinoma based on |
ESM1 | 35937390 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal |
ESM1 | 35937390 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal |
ESM1 | 35071405 | Prognostic | Unknown | Other | Cancer Related Esophageal | Identification of key genes associated with esophageal adenocarcinoma based on |
MCM7 | 38117512 | Prognostic | Unknown | Other | Esophageal cancer | Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive |
MCM7 | 26156831 | Prognostic | Unknown | Tissue | Esophageal cancer | High expression of carbonic anhydrase IX is significantly associated with |
MCM7 | 24805087 | Prognostic | Unknown | Tissue | Esophageal cancer | Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is |
MCM7 | 26156831 | Prognostic | Unknown | Tissue | Esophageal Adenocarcinoma | High expression of carbonic anhydrase IX is significantly associated with |
MCM7 | 38117512 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive |
MCM7 | 26156831 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | High expression of carbonic anhydrase IX is significantly associated with |
MCM7 | 24805087 | Prognostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is |
MCM7 | 26156831 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | High expression of carbonic anhydrase IX is significantly associated with |
CXCL8 | 38673838 | Prognostic | Unknown | Tissue | Esophageal cancer | Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis. |
CXCL8 | 37960824 | Prognostic | Upregulated | Other | Esophageal cancer | A pan-cancer analysis of the MAPK family gene and their association with |
CXCL8 | 37197539 | Prognostic | Unknown | Other | Esophageal cancer | Immune characteristics and genetic markers of esophageal cancer by single-cell |
CXCL8 | 37960824 | Prognostic | Upregulated | Other | Esophageal Adenocarcinoma | A pan-cancer analysis of the MAPK family gene and their association with |
CXCL8 | 31773415 | Prognostic | Unknown | Other | Esophageal Adenocarcinoma | Chemokines and their receptors as biomarkers in esophageal cancer. |
CXCL8 | 33710809 | Prognostic | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via |
CXCL8 | 33517283 | Prognostic | Unknown | Cell lines | Esophageal Squamous Cell Carcinoma | IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell |
CXCL8 | 31773415 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | Chemokines and their receptors as biomarkers in esophageal cancer. |
CXCL8 | 38673838 | Prognostic | Unknown | Tissue | Cancer Related Esophageal | Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis. |
CXCL8 | 37960824 | Prognostic | Upregulated | Other | Cancer Related Esophageal | A pan-cancer analysis of the MAPK family gene and their association with |
CXCL8 | 37197539 | Prognostic | Unknown | Other | Cancer Related Esophageal | Immune characteristics and genetic markers of esophageal cancer by single-cell |
CXCL8 | 32851080 | Prognostic | Unknown | Other | Cancer Related Esophageal | Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer |
CXCL8 | 31748958 | Prognostic | Unknown | Other | Cancer Related Esophageal | The prognostic role of FZD6 in esophageal squamous cell carcinoma patients. |
KPNA2 | 20393006 | Prognostic | Unknown | Other | Esophageal cancer | Significance of karyopherin-alpha 2 (KPNA2) expression in esophageal squamous |
KPNA2 | 20393006 | Prognostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | Significance of karyopherin-alpha 2 (KPNA2) expression in esophageal squamous |
KPNA2 | 20393006 | Prognostic | Unknown | Other | Cancer Related Esophageal | Significance of karyopherin-alpha 2 (KPNA2) expression in esophageal squamous |
ISG15 | 26617815 | Prognostic | Upregulated | Tissue | Esophageal cancer | Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell |
ISG15 | 26617815 | Prognostic | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell |
SEMA3F | 34760691 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Bioinformatics Analysis Using ATAC-seq and RNA-seq for the Identification of 15 |
SEMA3F | 34760691 | Prognostic | Unknown | Tissue | Liver Cancer | Bioinformatics Analysis Using ATAC-seq and RNA-seq for the Identification of 15 |
MARCO | 38806553 | Prognostic | Unknown | Blood | Hepatocellular Carcinoma | Multi-omics analysis of macrophage-associated receptor and ligand reveals a |
MARCO | 38512627 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Imaging and prognostic characterization of fat-containing hepatocellular |
MARCO | 38341377 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: |
MARCO | 38806553 | Prognostic | Unknown | Blood | Liver Cancer | Multi-omics analysis of macrophage-associated receptor and ligand reveals a |
MARCO | 38512627 | Prognostic | Unknown | Tissue | Liver Cancer | Imaging and prognostic characterization of fat-containing hepatocellular |
MARCO | 36646615 | Prognostic | Unknown | Other | Bile duct cancer | Management and outcomes of mixed adenoneuroendocrine carcinoma of the ampulla of |
MARCO | 38806553 | Prognostic | Unknown | Blood | Cancer Related Liver | Multi-omics analysis of macrophage-associated receptor and ligand reveals a |
NOX4 | 37626693 | Prognostic | Upregulated | Tissue | Hepatocellular Carcinoma | Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its |
NOX4 | 37157887 | Prognostic | Unknown | Other | Liver Cancer | Spatial resolution of cellular senescence dynamics in human colorectal liver |
SLC5A1 | 37786439 | Prognostic | Upregulated | Other | Hepatocellular Carcinoma | Comprehensive Analysis of Sideroflexin 4 in Hepatocellular Carcinoma by |
SLC5A1 | 37786439 | Prognostic | Upregulated | Other | Liver Cancer | Comprehensive Analysis of Sideroflexin 4 in Hepatocellular Carcinoma by |
SLC5A1 | 37786439 | Prognostic | Upregulated | Other | Cancer Related Liver | Comprehensive Analysis of Sideroflexin 4 in Hepatocellular Carcinoma by |
PVALB | 38737383 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related |
PVALB | 38737383 | Prognostic | Unknown | Tissue | Liver Cancer | PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related |
PVALB | 38737383 | Prognostic | Unknown | Tissue | Cancer Related Liver | PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related |
CDKN3 | 35030478 | Prognostic | Upregulated | Other | Hepatocellular Carcinoma | Development of a prognostic gene signature for hepatocellular carcinoma. |
CDKN3 | 34336642 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and |
CDKN3 | 34315286 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Global analysis of gene expression signature and diagnostic/prognostic biomarker |
CDKN3 | 33946043 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and |
CDKN3 | 35030478 | Prognostic | Upregulated | Other | Liver Cancer | Development of a prognostic gene signature for hepatocellular carcinoma. |
CDKN3 | 34336642 | Prognostic | Unknown | Tissue | Liver Cancer | Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and |
CDKN3 | 34315286 | Prognostic | Unknown | Other | Liver Cancer | Global analysis of gene expression signature and diagnostic/prognostic biomarker |
CDKN3 | 33946043 | Prognostic | Unknown | Other | Liver Cancer | Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and |
CDKN3 | 33784984 | Prognostic | Unknown | Tissue | Liver Cancer | Six genes involved in prognosis of hepatocellular carcinoma identified by Cox |
CDKN3 | 37504265 | Prognostic | Unknown | Tissue | Bile duct cancer | Exploring Key Biomarkers and Common Pathogenesis of Seven Digestive System |
CDKN3 | 34336642 | Prognostic | Unknown | Tissue | Cancer Related Liver | Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and |
CDKN3 | 32721244 | Prognostic | Unknown | Other | Cancer Related Liver | CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity |
CDKN3 | 32000807 | Prognostic | Unknown | Tissue | Cancer Related Liver | Bioinformatics-based screening of key genes for transformation of liver cirrhosis |
CLEC4M | 38683466 | Prognostic | Downregulated | Tissue | Hepatocellular Carcinoma | Identification of Hub Genes in Liver Hepatocellular Carcinoma Based on Weighted |
CLEC4M | 34409028 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma |
CLEC4M | 32194663 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | High expression levels of CLEC4M indicate poor prognosis in patients with |
CLEC4M | 38683466 | Prognostic | Downregulated | Tissue | Liver Cancer | Identification of Hub Genes in Liver Hepatocellular Carcinoma Based on Weighted |
CLEC4M | 34409028 | Prognostic | Unknown | Tissue | Liver Cancer | CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma |
CLEC4M | 34409028 | Prognostic | Unknown | Tissue | Cancer Related Liver | CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma |
THBS4 | 33753986 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Identification of hub genes-based predictive model in hepatocellular carcinoma by |
THBS4 | 30802535 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinoma. |
THBS4 | 29025594 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Gene expression profiling, pathway analysis and subtype classification reveal |
THBS4 | 35768842 | Prognostic | Unknown | Tissue | Liver Cancer | Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like |
THBS4 | 30802535 | Prognostic | Unknown | Tissue | Liver Cancer | Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinoma. |
THBS4 | 29025594 | Prognostic | Unknown | Other | Liver Cancer | Gene expression profiling, pathway analysis and subtype classification reveal |
THBS4 | 35768842 | Prognostic | Unknown | Tissue | Cancer Related Liver | Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like |
THBS4 | 30802535 | Prognostic | Unknown | Tissue | Cancer Related Liver | Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinoma. |
THBS4 | 29025594 | Prognostic | Unknown | Other | Cancer Related Liver | Gene expression profiling, pathway analysis and subtype classification reveal |
SCAMP3 | 33437366 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular |
SCAMP3 | 33116758 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Comprehensive Evaluation of Endocytosis-Associated Protein SCAMP3 in |
SCAMP3 | 32431518 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via |
SCAMP3 | 32099407 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Bioinformatics Analysis and RNA-Sequencing of SCAMP3 Expression and Correlated |
SCAMP3 | 29312605 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular |
PLVAP | 36238304 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | CEP192 is a novel prognostic marker and correlates with the immune |
PLVAP | 36238304 | Prognostic | Unknown | Other | Liver Cancer | CEP192 is a novel prognostic marker and correlates with the immune |
ANGPTL6 | 34412629 | Prognostic | Upregulated | Tissue | Hepatocellular Carcinoma | Use of proteomics to identify mechanisms of hepatocellular carcinoma with the |
ANGPTL6 | 34412629 | Prognostic | Upregulated | Tissue | Liver Cancer | Use of proteomics to identify mechanisms of hepatocellular carcinoma with the |
ANGPTL6 | 23070965 | Prognostic | Unknown | Tissue | Liver Cancer | A complex of alpha6 integrin and E-cadherin drives liver metastasis of colorectal |
ANGPTL6 | 34412629 | Prognostic | Upregulated | Tissue | Cancer Related Liver | Use of proteomics to identify mechanisms of hepatocellular carcinoma with the |
B4GALNT1 | 37337736 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | B4GALNT1 promotes carcinogenesis by regulating epithelial-mesenchymal transition |
B4GALNT1 | 37337736 | Prognostic | Unknown | Tissue | Liver Cancer | B4GALNT1 promotes carcinogenesis by regulating epithelial-mesenchymal transition |
B4GALNT1 | 37337736 | Prognostic | Unknown | Tissue | Cancer Related Liver | B4GALNT1 promotes carcinogenesis by regulating epithelial-mesenchymal transition |
ARHGEF39 | 31626606 | Prognostic | Upregulated | Tissue | Hepatocellular Carcinoma | Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its |
ARHGEF39 | 30775801 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Prognostic genes of hepatocellular carcinoma based on gene coexpression network |
ARHGEF39 | 31626606 | Prognostic | Upregulated | Tissue | Liver Cancer | Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its |
ARHGEF39 | 30775801 | Prognostic | Unknown | Other | Liver Cancer | Prognostic genes of hepatocellular carcinoma based on gene coexpression network |
CEP131 | 28694105 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | CEP131 indicates poor prognosis and promotes cell proliferation and migration in |
CEP131 | 36008383 | Prognostic | Upregulated | Other | Liver Cancer | Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to |
CEP131 | 28694105 | Prognostic | Unknown | Tissue | Liver Cancer | CEP131 indicates poor prognosis and promotes cell proliferation and migration in |
CEP131 | 36008383 | Prognostic | Upregulated | Other | Cancer Related Liver | Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to |
PRCC | 32099407 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Bioinformatics Analysis and RNA-Sequencing of SCAMP3 Expression and Correlated |
PRCC | 38007857 | Prognostic | Unknown | Other | Liver Cancer | Potential role of (68)Ga-PSMA PET/CT in metastatic renal cell cancer: A |
CXCL14 | 37774952 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Construction of a diagnostic model for hepatitis B-related hepatocellular |
CXCL14 | 35928748 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Development and validation of an eight-gene signature based predictive model to |
CXCL14 | 34085699 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration |
CXCL14 | 33878734 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Identification of prognostic biomarkers associated with the occurrence of portal |
CXCL14 | 37774952 | Prognostic | Unknown | Other | Liver Cancer | Construction of a diagnostic model for hepatitis B-related hepatocellular |
CXCL14 | 34085699 | Prognostic | Unknown | Tissue | Liver Cancer | CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration |
CXCL14 | 33878734 | Prognostic | Unknown | Tissue | Liver Cancer | Identification of prognostic biomarkers associated with the occurrence of portal |
CXCL14 | 37774952 | Prognostic | Unknown | Other | Cancer Related Liver | Construction of a diagnostic model for hepatitis B-related hepatocellular |
CXCL14 | 34085699 | Prognostic | Unknown | Tissue | Cancer Related Liver | CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration |
FBXO43 | 38812312 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F |
FBXO43 | 37560338 | Prognostic | Upregulated | Tissue | Hepatocellular Carcinoma | High Expression of F-Box Protein 43 Is Associated With Poor Prognosis and |
FBXO43 | 36937431 | Prognostic | Upregulated | Tissue | Hepatocellular Carcinoma | FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell |
FBXO43 | 36710413 | Prognostic | Upregulated | Tissue | Hepatocellular Carcinoma | Association between F-box-only protein 43 overexpression and hepatocellular |
FBXO43 | 30775801 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Prognostic genes of hepatocellular carcinoma based on gene coexpression network |
FBXO43 | 38812312 | Prognostic | Unknown | Other | Liver Cancer | A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F |
FBXO43 | 36710413 | Prognostic | Upregulated | Tissue | Liver Cancer | Association between F-box-only protein 43 overexpression and hepatocellular |
FBXO43 | 30775801 | Prognostic | Unknown | Other | Liver Cancer | Prognostic genes of hepatocellular carcinoma based on gene coexpression network |
FBXO43 | 37560338 | Prognostic | Upregulated | Tissue | Cholangiocarcinoma | High Expression of F-Box Protein 43 Is Associated With Poor Prognosis and |
FBXO43 | 38812312 | Prognostic | Unknown | Other | Cancer Related Liver | A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F |
TOMM40L | 37745063 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Heterogeneity characterization of hepatocellular carcinoma based on the |
FCN2 | 38683466 | Prognostic | Downregulated | Tissue | Hepatocellular Carcinoma | Identification of Hub Genes in Liver Hepatocellular Carcinoma Based on Weighted |
FCN2 | 36425563 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Ficolin-2: A potential immune-related therapeutic target with low expression in |
FCN2 | 36157238 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma |
FCN2 | 35928441 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin |
FCN2 | 27177473 | Prognostic | Downregulated | Tissue | Hepatocellular Carcinoma | FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of |
FCN2 | 38683466 | Prognostic | Downregulated | Tissue | Liver Cancer | Identification of Hub Genes in Liver Hepatocellular Carcinoma Based on Weighted |
FCN2 | 36425563 | Prognostic | Unknown | Tissue | Liver Cancer | Ficolin-2: A potential immune-related therapeutic target with low expression in |
FCN2 | 36157238 | Prognostic | Unknown | Tissue | Liver Cancer | Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma |
FCN2 | 27177473 | Prognostic | Downregulated | Tissue | Liver Cancer | FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of |
FCN2 | 36425563 | Prognostic | Unknown | Tissue | Cancer Related Liver | Ficolin-2: A potential immune-related therapeutic target with low expression in |
FCN2 | 27177473 | Prognostic | Downregulated | Tissue | Cancer Related Liver | FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of |
BMPER | 38244582 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Identification and validation of methylation-CpG prognostic signature for |
BMPER | 38244582 | Prognostic | Unknown | Other | Liver Cancer | Identification and validation of methylation-CpG prognostic signature for |
BMPER | 38244582 | Prognostic | Unknown | Other | Cancer Related Liver | Identification and validation of methylation-CpG prognostic signature for |
APLN | 38114725 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Construction and validation of a novel lysosomal signature for hepatocellular |
APLN | 36304495 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on |
APLN | 31410213 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is |
APLN | 24966992 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Emerging role of adipokine apelin in hepatic remodelling and initiation of |
APLN | 38114725 | Prognostic | Unknown | Other | Liver Cancer | Construction and validation of a novel lysosomal signature for hepatocellular |
APLN | 31410213 | Prognostic | Unknown | Other | Liver Cancer | APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is |
APLN | 24966992 | Prognostic | Unknown | Other | Liver Cancer | Emerging role of adipokine apelin in hepatic remodelling and initiation of |
APLN | 38114725 | Prognostic | Unknown | Other | Cancer Related Liver | Construction and validation of a novel lysosomal signature for hepatocellular |
CD34 | 38538524 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | miR-215-5p Plays a Key Role in Suppressing Vascular Invasion and Recurrence in |
CD34 | 38538524 | Prognostic | Unknown | Tissue | Liver Cancer | miR-215-5p Plays a Key Role in Suppressing Vascular Invasion and Recurrence in |
CD34 | 34117554 | Prognostic | Unknown | Other | Bile duct cancer | Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the |
CD34 | 33077921 | Prognostic | Unknown | Blood | Bile duct cancer | Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: |
CD34 | 32841741 | Prognostic | Unknown | Tissue | Bile duct cancer | Carcinoembryonic antigen, alpha-fetoprotein, and Ki67 as biomarkers and prognostic |
CD34 | 37174934 | Prognostic | Unknown | Other | Cholangiocarcinoma | The Role of Immunohistochemistry in the Differential Diagnosis between |
CD34 | 34117554 | Prognostic | Unknown | Other | Cholangiocarcinoma | Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the |
CD34 | 33077921 | Prognostic | Unknown | Blood | Cholangiocarcinoma | Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: |
CD34 | 32841741 | Prognostic | Unknown | Tissue | Cholangiocarcinoma | Carcinoembryonic antigen, alpha-fetoprotein, and Ki67 as biomarkers and prognostic |
GBA | 38401352 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Survival benefit of adjuvant chemotherapy in patients with resected gallbladder |
GBA | 38170006 | Prognostic | Unknown | Cell lines | Hepatocellular Carcinoma | Identifying the programmed cell death index of hepatocellular carcinoma for |
GBA | 38114725 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Construction and validation of a novel lysosomal signature for hepatocellular |
GBA | 38223061 | Prognostic | Unknown | Other | Liver Cancer | Metabolic parameters of pretreatment 2-[(18)F]fluoro-D-glucose positron emission |
GBA | 38170006 | Prognostic | Unknown | Cell lines | Liver Cancer | Identifying the programmed cell death index of hepatocellular carcinoma for |
GBA | 38114725 | Prognostic | Unknown | Other | Liver Cancer | Construction and validation of a novel lysosomal signature for hepatocellular |
GBA | 38223061 | Prognostic | Unknown | Other | Cancer Related Liver | Metabolic parameters of pretreatment 2-[(18)F]fluoro-D-glucose positron emission |
GBA | 38170006 | Prognostic | Unknown | Cell lines | Cancer Related Liver | Identifying the programmed cell death index of hepatocellular carcinoma for |
GBA | 38114725 | Prognostic | Unknown | Other | Cancer Related Liver | Construction and validation of a novel lysosomal signature for hepatocellular |
TIGD5 | 30138346 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Identification of biomarkers for Barcelona Clinic Liver Cancer staging and |
TIGD5 | 30138346 | Prognostic | Unknown | Tissue | Liver Cancer | Identification of biomarkers for Barcelona Clinic Liver Cancer staging and |
COLEC10 | 36925047 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | COLEC10 Induces Endoplasmic Reticulum Stress by Occupying GRP78 and Inhibits |
COLEC10 | 35397600 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular |
COLEC10 | 34707365 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker |
COLEC10 | 30122986 | Prognostic | Downregulated | Tissue | Hepatocellular Carcinoma | Decreased expression of COLEC10 predicts poor overall survival in patients with |
COLEC10 | 36925047 | Prognostic | Unknown | Tissue | Liver Cancer | COLEC10 Induces Endoplasmic Reticulum Stress by Occupying GRP78 and Inhibits |
COLEC10 | 35397600 | Prognostic | Unknown | Tissue | Liver Cancer | A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular |
COLEC10 | 34707365 | Prognostic | Unknown | Other | Liver Cancer | A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker |
COLEC10 | 30122986 | Prognostic | Downregulated | Tissue | Liver Cancer | Decreased expression of COLEC10 predicts poor overall survival in patients with |
COLEC10 | 35397600 | Prognostic | Unknown | Tissue | Cancer Related Liver | A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular |
COLEC10 | 34707365 | Prognostic | Unknown | Other | Cancer Related Liver | A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker |
COLEC10 | 30122986 | Prognostic | Downregulated | Tissue | Cancer Related Liver | Decreased expression of COLEC10 predicts poor overall survival in patients with |
COL15A1 | 37892853 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | An Efficient Binary Sand Cat Swarm Optimization for Feature Selection in |
COL15A1 | 35512233 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | A novel four-gene signature for predicting the prognosis of hepatocellular |
COL15A1 | 31754347 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Two predictive precision medicine tools for hepatocellular carcinoma. |
COL15A1 | 37892853 | Prognostic | Unknown | Other | Liver Cancer | An Efficient Binary Sand Cat Swarm Optimization for Feature Selection in |
COL15A1 | 35512233 | Prognostic | Unknown | Tissue | Liver Cancer | A novel four-gene signature for predicting the prognosis of hepatocellular |
COL15A1 | 35512233 | Prognostic | Unknown | Tissue | Cancer Related Liver | A novel four-gene signature for predicting the prognosis of hepatocellular |
MXD3 | 30775801 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Prognostic genes of hepatocellular carcinoma based on gene coexpression network |
MXD3 | 30775801 | Prognostic | Unknown | Other | Liver Cancer | Prognostic genes of hepatocellular carcinoma based on gene coexpression network |
SLC26A6 | 35116598 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Systemic characterization of the SLC family genes reveals SLC26A6 as a novel |
SLC26A6 | 34591393 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | Up-Regulation of SLC26A6 in Hepatocellular Carcinoma and Its Diagnostic and |
SLC26A6 | 34591393 | Prognostic | Unknown | Other | Liver Cancer | Up-Regulation of SLC26A6 in Hepatocellular Carcinoma and Its Diagnostic and |
SLC26A6 | 34591393 | Prognostic | Unknown | Other | Cancer Related Liver | Up-Regulation of SLC26A6 in Hepatocellular Carcinoma and Its Diagnostic and |
TERT | 38760594 | Prognostic | Unknown | Tissue | Hepatocellular Carcinoma | Beyond histology: A tissue algorithm predictive of post-surgical recurrence in |
TERT | 38665910 | Prognostic | Unknown | Other | Hepatocellular Carcinoma | The predictive value of next generation sequencing for matching advanced |
TERT | 38665910 | Prognostic | Unknown | Other | Liver Cancer | The predictive value of next generation sequencing for matching advanced |
TERT | 38463590 | Prognostic | Unknown | Other | Liver Cancer | Complex phenotypic heterogeneity of combined hepatocellular-cholangiocarcinoma |
TERT | 37222808 | Prognostic | Unknown | Other | Bile duct cancer | Development and validation of a gene expression-based nomogram to predict the |
TERT | 38463590 | Prognostic | Unknown | Other | Cholangiocarcinoma | Complex phenotypic heterogeneity of combined hepatocellular-cholangiocarcinoma |
TERT | 37222808 | Prognostic | Unknown | Other | Cholangiocarcinoma | Development and validation of a gene expression-based nomogram to predict the |
TERT | 36788061 | Prognostic | Unknown | Other | Cholangiocarcinoma | Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common |
TERT | 38463590 | Prognostic | Unknown | Other | Cancer Related Liver | Complex phenotypic heterogeneity of combined hepatocellular-cholangiocarcinoma |
CACNG3 | 37794108 | Prognostic | Unknown | Other | Pancreatic Cancer | Down regulation of Cathepsin W is associated with poor prognosis in pancreatic |
CACNG3 | 37794108 | Prognostic | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Down regulation of Cathepsin W is associated with poor prognosis in pancreatic |
ZIC2 | 35390314 | Prognostic | Unknown | Other | Pancreatic Cancer | ZIC2 promotes colorectal cancer growth and metastasis through the TGF-beta signaling |
SPI1 | 38764850 | Prognostic | Upregulated | Plasma | Pancreatic Cancer | Identification of differentially expressed mRNAs as novel predictive biomarkers |
SNX10 | 30487700 | Prognostic | Unknown | Tissue | Pancreatic Cancer | Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma |
FXYD3 | 29650332 | Prognostic | Unknown | Other | Pancreatic Cancer | Clinicopathological and prognostic significance of MUC13 and AGR2 expression in |
FXYD3 | 29650332 | Prognostic | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Clinicopathological and prognostic significance of MUC13 and AGR2 expression in |
HMOX1 | 37653101 | Prognostic | Unknown | Tissue | Pancreatic Cancer | An endoplasmic reticulum stress-related signature could robustly predict |
HMOX1 | 37653101 | Prognostic | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | An endoplasmic reticulum stress-related signature could robustly predict |
PDYN | 38325047 | Prognostic | Unknown | Other | Pancreatic Cancer | A novel investigation into the negative impact of opioid use on the efficacy of |
HCK | 34630563 | Prognostic | Unknown | Other | Pancreatic Cancer | Molecular Analysis of Prognosis and Immune Pathways of Pancreatic Cancer Based on |
FAM83D | 36710419 | Prognostic | Unknown | Tissue | Pancreatic Cancer | Systematic analysis of the oncogenic role of FAM83D across cancers based on data |
FAM83D | 33747255 | Prognostic | Upregulated | Other | Pancreatic Cancer | Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family |
FAM83D | 33747255 | Prognostic | Upregulated | Other | Pancreatic Ductal Adenocarcinoma | Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family |
LILRB1 | 37382674 | Prognostic | Unknown | Other | Pancreatic Cancer | A novel prognostic signature based on immunogenic cell death score predicts |
LILRB1 | 34778091 | Prognostic | Unknown | Tissue | Pancreatic Cancer | The Scavenger Receptor MARCO Expressed by Tumor-Associated Macrophages Are Highly |
LILRB1 | 32534335 | Prognostic | Upregulated | Other | Pancreatic Cancer | Leukocyte immunoglobulin-like receptor subfamily B member 1 potentially acts as a |
LILRB1 | 32534335 | Prognostic | Upregulated | Other | Pancreatic Ductal Adenocarcinoma | Leukocyte immunoglobulin-like receptor subfamily B member 1 potentially acts as a |
CD33 | 33262135 | Prognostic | Unknown | Other | Pancreatic Cancer | Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell |
CD33 | 32905653 | Prognostic | Unknown | Blood | Pancreatic Cancer | Circulating CD14(+) HLA-DR(lo/-) monocytic cells as a biomarker for epithelial |
CD33 | 32132105 | Prognostic | Unknown | Blood | Pancreatic Cancer | Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX |
CD33 | 29886672 | Prognostic | Unknown | Other | Pancreatic Cancer | [Prognostic value of tumor infiltration immune cells in pancreatic cancer]. |
CD33 | 33262135 | Prognostic | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell |
TNFAIP3 | 33578593 | Prognostic | Unknown | Blood | Pancreatic Cancer | The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with |
TNFAIP3 | 34113123 | Prognostic | Unknown | Saliva | Pancreatic Ductal Adenocarcinoma | Targeted-Gene Sequencing and Bioinformatics Analysis of Patients with Pancreatic |
TNFAIP3 | 33578593 | Prognostic | Unknown | Blood | Pancreatic Ductal Adenocarcinoma | The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with |
TNFAIP3 | 34113123 | Prognostic | Unknown | Saliva | Cancer Related Pancreas | Targeted-Gene Sequencing and Bioinformatics Analysis of Patients with Pancreatic |
SPDEF | 38617519 | Prognostic | Unknown | Tissue | Pancreatic Cancer | Modeling of new markers for the diagnosis and prognosis of pancreatic cancer |
SPDEF | 38520747 | Prognostic | Unknown | Other | Pancreatic Cancer | SPDEF drives pancreatic adenocarcinoma progression via transcriptional |
DDC | 38617519 | Prognostic | Unknown | Tissue | Pancreatic Cancer | Modeling of new markers for the diagnosis and prognosis of pancreatic cancer |
ERN2 | 37653101 | Prognostic | Unknown | Tissue | Pancreatic Cancer | An endoplasmic reticulum stress-related signature could robustly predict |
ERN2 | 37653101 | Prognostic | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | An endoplasmic reticulum stress-related signature could robustly predict |
NPL | 35786807 | Prognostic | Unknown | Blood | Pancreatic Cancer | Assessment of peripheral blood cells parameters as a valuable tool in patients |
NPL | 33159546 | Prognostic | Unknown | Other | Pancreatic Cancer | Prognostic significance of dissecting the nerve plexus around the common hepatic |
FHDC1 | 36523322 | Prognostic | Unknown | Other | Pancreatic Cancer | Prognostic biomarkers of pancreatic cancer identified based on a competing |
FHDC1 | 35248692 | Prognostic | Unknown | Other | Pancreatic Cancer | A 70‑RNA model based on SVR and RFE for predicting the pancreatic cancer clinical |
RASGRP3 | 22687285 | Prognostic | Unknown | Tissue | Pancreatic Cancer | Hepatoma cells from mice deficient in glycine N-methyltransferase have increased |
CYP3A4 | 34992435 | Prognostic | Unknown | Tissue | Pancreatic Cancer | Single-Cell Sequencing of Hepatocellular Carcinoma Reveals Cell Interactions and |
PPP1R14D | 34732125 | Prognostic | Unknown | Other | Pancreatic Cancer | Identification of DNA methylation-driven genes and construction of a nomogram to |
LAIR1 | 36773567 | Prognostic | Unknown | Tissue | Pancreatic Cancer | MARCO is a potential prognostic and immunotherapy biomarker. |
ADAP2 | 37794108 | Prognostic | Unknown | Other | Pancreatic Cancer | Down regulation of Cathepsin W is associated with poor prognosis in pancreatic |
ADAP2 | 37794108 | Prognostic | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Down regulation of Cathepsin W is associated with poor prognosis in pancreatic |
CDH3 | 29142905 | Prognostic | Unknown | Tissue | Rectal Cancer | P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a |
SALL4 | 38556821 | Prognostic | Unknown | Other | Rectum Cancer | [Colorectal adenocarcinoma with enteroblastic differentiation: a |
MDFI | 25472652 | Prognostic | Unknown | Tissue | Rectal Cancer | Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients |
MDFI | 25472652 | Prognostic | Unknown | Tissue | Rectum Cancer | Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients |
TGFBI | 34295549 | Prognostic | Unknown | Other | Rectal Cancer | Identification of gene biomarkers and immune cell infiltration characteristics in |
CBX8 | 33014884 | Prognostic | Unknown | Tissue | Rectal Cancer | Comprehensive Analysis of Prognostic Value and Immune Infiltration of Chromobox |
SST | 33580586 | Prognostic | Unknown | Tissue | Rectal Cancer | DNA methylation markers have universal prognostic value for anal cancer risk in |
SST | 33580586 | Prognostic | Unknown | Tissue | Rectum Cancer | DNA methylation markers have universal prognostic value for anal cancer risk in |
ESM1 | 27470607 | Prognostic | Unknown | Blood | Rectal Cancer | Prognostic value of endocan in prostate cancer: clinicopathologic association |
ESM1 | 27470607 | Prognostic | Unknown | Blood | Rectum Cancer | Prognostic value of endocan in prostate cancer: clinicopathologic association |
OTOP3 | 35587572 | Prognostic | Unknown | Tissue | Rectum Cancer | Prognosis prediction of stage IV colorectal cancer patients by mRNA |
OTOP3 | 35587572 | Prognostic | Unknown | Tissue | Cancer Related Rectum | Prognosis prediction of stage IV colorectal cancer patients by mRNA |
HOXC8 | 36924407 | Prognostic | Unknown | Other | Stomach Cancer | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC8 | 37670969 | Prognostic | Unknown | Tissue | Gastric Cancer | HOXC8 mediates osteopontin expression in gastric cancer cells. |
HOXC8 | 36924407 | Prognostic | Unknown | Other | Gastric Cancer | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC8 | 36924407 | Prognostic | Unknown | Other | Cancer Related Stomach | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
FAP | 38546071 | Prognostic | Unknown | Plasma | Stomach Cancer | Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on |
FAP | 38546071 | Prognostic | Unknown | Plasma | Gastric Cancer | Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on |
FAP | 38546071 | Prognostic | Unknown | Plasma | Cancer Related Stomach | Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on |
FAP | 37277751 | Prognostic | Unknown | Other | Cancer Related Stomach | FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by |
FAP | 37068372 | Prognostic | Unknown | Cell lines | Cancer Related Stomach | Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated |
FAP | 36650362 | Prognostic | Upregulated | Other | Cancer Related Stomach | Comprehensive analysis of immune subtypes reveals the prognostic value of |
ANGPT2 | 36092336 | Prognostic | Upregulated | Other | Stomach Cancer | Identification of candidate biomarkers associated with gastric cancer prognosis |
ANGPT2 | 35987690 | Prognostic | Upregulated | Other | Stomach Cancer | MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis |
ANGPT2 | 32801780 | Prognostic | Unknown | Other | Stomach Cancer | The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach |
ANGPT2 | 31772663 | Prognostic | Unknown | Other | Stomach Cancer | Genome-wide analysis to identify a novel microRNA signature that predicts |
ANGPT2 | 25577146 | Prognostic | Unknown | Tissue | Stomach Cancer | Angiogenic and growth factors in gastric cancer. |
ANGPT2 | 36092336 | Prognostic | Upregulated | Other | Gastric Cancer | Identification of candidate biomarkers associated with gastric cancer prognosis |
ANGPT2 | 35987690 | Prognostic | Upregulated | Other | Gastric Cancer | MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis |
ANGPT2 | 25577146 | Prognostic | Unknown | Tissue | Gastric Cancer | Angiogenic and growth factors in gastric cancer. |
ANGPT2 | 20005068 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Gene expression profile towards the prediction of patient survival of gastric |
MMP11 | 37679111 | Prognostic | Unknown | Tissue | Stomach Cancer | Identification and validation of biomarkers for epithelial-mesenchymal |
MMP11 | 37410142 | Prognostic | Unknown | Cell lines | Stomach Cancer | Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem |
MMP11 | 36044785 | Prognostic | Unknown | Other | Stomach Cancer | Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic |
MMP11 | 32309437 | Prognostic | Unknown | Other | Stomach Cancer | Identification and Validation of an Individualized EMT-Related Prognostic Risk |
MMP11 | 37679111 | Prognostic | Unknown | Tissue | Gastric Cancer | Identification and validation of biomarkers for epithelial-mesenchymal |
MMP11 | 37410142 | Prognostic | Unknown | Cell lines | Gastric Cancer | Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem |
MMP11 | 36044785 | Prognostic | Unknown | Other | Gastric Cancer | Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic |
MMP11 | 36010928 | Prognostic | Unknown | Other | Gastric Cancer | Relationship of FDG PET/CT Textural Features with the Tumor Microenvironment and |
MMP11 | 32922036 | Prognostic | Unknown | Tissue | Gastric Cancer | Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion |
MMP11 | 32309437 | Prognostic | Unknown | Other | Gastric Cancer | Identification and Validation of an Individualized EMT-Related Prognostic Risk |
MMP11 | 37679111 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Identification and validation of biomarkers for epithelial-mesenchymal |
MMP11 | 37410142 | Prognostic | Unknown | Cell lines | Cancer Related Stomach | Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem |
MMP11 | 36044785 | Prognostic | Unknown | Other | Cancer Related Stomach | Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic |
MMP11 | 32309437 | Prognostic | Unknown | Other | Cancer Related Stomach | Identification and Validation of an Individualized EMT-Related Prognostic Risk |
MMP11 | 23151184 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Overexpression of Snail is associated with lymph node metastasis and poor |
CST4 | 37978366 | Prognostic | Unknown | Tissue | Stomach Cancer | Investigating the prognostic and predictive value of the type II cystatin genes |
CST4 | 37978366 | Prognostic | Unknown | Tissue | Gastric Cancer | Investigating the prognostic and predictive value of the type II cystatin genes |
CST4 | 37978366 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Investigating the prognostic and predictive value of the type II cystatin genes |
RIPK2 | 35508972 | Prognostic | Unknown | Tissue | Gastric Cancer | Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy |
DNAJC2 | 29228320 | Prognostic | Unknown | Cell lines | Stomach Cancer | Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome |
DNAJC2 | 29228320 | Prognostic | Unknown | Cell lines | Gastric Cancer | Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome |
DNAJC2 | 29228320 | Prognostic | Unknown | Cell lines | Cancer Related Stomach | Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome |
WNT2 | 36355210 | Prognostic | Unknown | Tissue | Stomach Cancer | miRNA-223-3p regulates ECT2 to promote proliferation, invasion, and metastasis of |
WNT2 | 35037695 | Prognostic | Unknown | Tissue | Stomach Cancer | Overexpression of IL-8 and Wnt2 is associated with prognosis of gastric cancer. |
WNT2 | 33002344 | Prognostic | Upregulated | Tissue | Stomach Cancer | Screening lncRNAs with diagnostic and prognostic value for human stomach |
WNT2 | 32091407 | Prognostic | Unknown | Tissue | Stomach Cancer | SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/beta-catenin |
WNT2 | 31409903 | Prognostic | Upregulated | Tissue | Stomach Cancer | Circular RNA profile identifies circOSBPL10 as an oncogenic factor and prognostic |
WNT2 | 36355210 | Prognostic | Unknown | Tissue | Gastric Cancer | miRNA-223-3p regulates ECT2 to promote proliferation, invasion, and metastasis of |
WNT2 | 35037695 | Prognostic | Unknown | Tissue | Gastric Cancer | Overexpression of IL-8 and Wnt2 is associated with prognosis of gastric cancer. |
WNT2 | 34215253 | Prognostic | Unknown | Tissue | Gastric Cancer | A novel strategy to identify candidate diagnostic and prognostic biomarkers for |
WNT2 | 33002344 | Prognostic | Upregulated | Tissue | Cancer Related Stomach | Screening lncRNAs with diagnostic and prognostic value for human stomach |
E2F3 | 30487158 | Prognostic | Unknown | Other | Stomach Cancer | Prognostic values of E2F mRNA expression in human gastric cancer. |
E2F3 | 37504265 | Prognostic | Unknown | Tissue | Gastric Cancer | Exploring Key Biomarkers and Common Pathogenesis of Seven Digestive System |
E2F3 | 34532281 | Prognostic | Unknown | Tissue | Gastric Cancer | Comprehensive Analysis of E2F Family Members in Human Gastric Cancer. |
E2F3 | 30487158 | Prognostic | Unknown | Other | Cancer Related Stomach | Prognostic values of E2F mRNA expression in human gastric cancer. |
INHBA | 38546071 | Prognostic | Unknown | Plasma | Stomach Cancer | Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on |
INHBA | 36064338 | Prognostic | Unknown | Tissue | Stomach Cancer | Prognostic impact of activin subunit inhibin beta A in gastric and esophageal |
INHBA | 35624327 | Prognostic | Unknown | Tissue | Stomach Cancer | CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients |
INHBA | 35299682 | Prognostic | Unknown | Other | Stomach Cancer | Identification of Immune-Related Prognostic Markers in Gastric Cancer. |
INHBA | 34968391 | Prognostic | Upregulated | Other | Stomach Cancer | Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of |
INHBA | 38546071 | Prognostic | Unknown | Plasma | Gastric Cancer | Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on |
INHBA | 37056863 | Prognostic | Unknown | Tissue | Gastric Cancer | A prognostic model based on the COL1A1-network in gastric cancer. |
INHBA | 36064338 | Prognostic | Unknown | Tissue | Gastric Cancer | Prognostic impact of activin subunit inhibin beta A in gastric and esophageal |
INHBA | 35624327 | Prognostic | Unknown | Tissue | Gastric Cancer | CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients |
INHBA | 38546071 | Prognostic | Unknown | Plasma | Cancer Related Stomach | Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on |
INHBA | 35624327 | Prognostic | Unknown | Tissue | Cancer Related Stomach | CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients |
INHBA | 35299682 | Prognostic | Unknown | Other | Cancer Related Stomach | Identification of Immune-Related Prognostic Markers in Gastric Cancer. |
INHBA | 34968391 | Prognostic | Upregulated | Other | Cancer Related Stomach | Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of |
INHBA | 24778035 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Relation of INHBA gene expression to outcomes in gastric cancer after curative |
HOXC11 | 36924407 | Prognostic | Unknown | Other | Stomach Cancer | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC11 | 36852074 | Prognostic | Unknown | Tissue | Stomach Cancer | Hsa_circ_0072309 is a prognostic biomarker and is correlated with immune |
HOXC11 | 36924407 | Prognostic | Unknown | Other | Gastric Cancer | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC11 | 36852074 | Prognostic | Unknown | Tissue | Gastric Cancer | Hsa_circ_0072309 is a prognostic biomarker and is correlated with immune |
HOXC11 | 36924407 | Prognostic | Unknown | Other | Cancer Related Stomach | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC11 | 36852074 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Hsa_circ_0072309 is a prognostic biomarker and is correlated with immune |
COL10A1 | 37996637 | Prognostic | Upregulated | Other | Stomach Cancer | Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for |
COL10A1 | 35874675 | Prognostic | Unknown | Other | Stomach Cancer | Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA |
COL10A1 | 35004767 | Prognostic | Unknown | Tissue | Stomach Cancer | Development and Validation of a Novel Prognosis Prediction Model for Patients |
COL10A1 | 34380365 | Prognostic | Unknown | Other | Stomach Cancer | A detailed understanding of the COL10A1 and SOX9 genes interaction based on |
COL10A1 | 33371777 | Prognostic | Upregulated | Tissue | Stomach Cancer | Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic |
COL10A1 | 33002344 | Prognostic | Upregulated | Tissue | Stomach Cancer | Screening lncRNAs with diagnostic and prognostic value for human stomach |
COL10A1 | 32801780 | Prognostic | Unknown | Other | Stomach Cancer | The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach |
COL10A1 | 37996637 | Prognostic | Upregulated | Other | Gastric Cancer | Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for |
COL10A1 | 37006317 | Prognostic | Upregulated | Tissue | Gastric Cancer | Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune |
COL10A1 | 36276283 | Prognostic | Upregulated | Tissue | Gastric Cancer | High Expression of COL10A1 Is an Independent Predictive Poor Prognostic Biomarker |
COL10A1 | 35910202 | Prognostic | Unknown | Other | Gastric Cancer | Identification and Verification of Potential Biomarkers in Gastric Cancer By |
COL10A1 | 35874675 | Prognostic | Unknown | Other | Gastric Cancer | Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA |
COL10A1 | 35726219 | Prognostic | Upregulated | Tissue | Gastric Cancer | Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor |
COL10A1 | 34380365 | Prognostic | Unknown | Other | Gastric Cancer | A detailed understanding of the COL10A1 and SOX9 genes interaction based on |
COL10A1 | 35004767 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Development and Validation of a Novel Prognosis Prediction Model for Patients |
COL10A1 | 34380365 | Prognostic | Unknown | Other | Cancer Related Stomach | A detailed understanding of the COL10A1 and SOX9 genes interaction based on |
COL10A1 | 33371777 | Prognostic | Upregulated | Tissue | Cancer Related Stomach | Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic |
COL10A1 | 33002344 | Prognostic | Upregulated | Tissue | Cancer Related Stomach | Screening lncRNAs with diagnostic and prognostic value for human stomach |
ADAMTS18 | 35874675 | Prognostic | Unknown | Other | Stomach Cancer | Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA |
ADAMTS18 | 35874675 | Prognostic | Unknown | Other | Gastric Cancer | Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA |
SERPINH1 | 35058967 | Prognostic | Upregulated | Tissue | Stomach Cancer | SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune |
SERPINH1 | 33193601 | Prognostic | Upregulated | Tissue | Stomach Cancer | Identification of Potential Core Genes Associated With the Progression of Stomach |
SERPINH1 | 32091407 | Prognostic | Unknown | Tissue | Stomach Cancer | SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/beta-catenin |
SERPINH1 | 29921304 | Prognostic | Upregulated | Other | Stomach Cancer | Identification of hub genes with prognostic values in gastric cancer by |
SERPINH1 | 36647484 | Prognostic | Unknown | Tissue | Gastric Cancer | High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma. |
SERPINH1 | 34215253 | Prognostic | Unknown | Tissue | Gastric Cancer | A novel strategy to identify candidate diagnostic and prognostic biomarkers for |
SERPINH1 | 33193601 | Prognostic | Upregulated | Tissue | Gastric Cancer | Identification of Potential Core Genes Associated With the Progression of Stomach |
SERPINH1 | 32091407 | Prognostic | Unknown | Tissue | Gastric Cancer | SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/beta-catenin |
SERPINH1 | 35058967 | Prognostic | Upregulated | Tissue | Cancer Related Stomach | SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune |
SERPINH1 | 29921304 | Prognostic | Upregulated | Other | Cancer Related Stomach | Identification of hub genes with prognostic values in gastric cancer by |
SERPINH1 | 9067768 | Prognostic | Unknown | Cell lines | Cancer Related Stomach | Specific expression of HSP47 in human tumor cell lines in vitro. |
ADAMTS12 | 37619822 | Prognostic | Unknown | Tissue | Stomach Cancer | ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer |
ADAMTS12 | 32801780 | Prognostic | Unknown | Other | Stomach Cancer | The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach |
ADAMTS12 | 37619822 | Prognostic | Unknown | Tissue | Gastric Cancer | ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer |
ADAMTS12 | 36388039 | Prognostic | Unknown | Other | Gastric Cancer | Novel insight on predicting prognosis of gastric cancer based on inflammation. |
ADAMTS12 | 32908454 | Prognostic | Unknown | Other | Gastric Cancer | Establishment of a 5-gene risk model related to regulatory T cells for predicting |
ADAMTS12 | 32884571 | Prognostic | Unknown | Tissue | Gastric Cancer | Prognostic Values for the mRNA Expression of the ADAMTS Family of Genes in |
ADAMTS12 | 32355745 | Prognostic | Upregulated | Tissue | Gastric Cancer | ADAMTS12 acts as a cancer promoter in colorectal cancer via activating the |
ADAMTS12 | 37206585 | Prognostic | Unknown | Tissue | Gastric Cancer | Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric |
ATAD2 | 31746426 | Prognostic | Upregulated | Tissue | Stomach Cancer | ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of |
ATAD2 | 26527032 | Prognostic | Unknown | Tissue | Stomach Cancer | ATAD2 is overexpressed in gastric cancer and serves as an independent poor |
ATAD2 | 32021447 | Prognostic | Upregulated | Tissue | Gastric Cancer | Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 |
ATAD2 | 31746426 | Prognostic | Upregulated | Tissue | Gastric Cancer | ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of |
ATAD2 | 26527032 | Prognostic | Unknown | Tissue | Gastric Cancer | ATAD2 is overexpressed in gastric cancer and serves as an independent poor |
ATAD2 | 31746426 | Prognostic | Upregulated | Tissue | Cancer Related Stomach | ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of |
ATAD2 | 26527032 | Prognostic | Unknown | Tissue | Cancer Related Stomach | ATAD2 is overexpressed in gastric cancer and serves as an independent poor |
CLEC3B | 29151948 | Prognostic | Unknown | Plasma | Gastric Cancer | High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of |
ESM1 | 38714987 | Prognostic | Unknown | Other | Stomach Cancer | Comprehensive analysis of T-cell regulatory factors and tumor immune |
ESM1 | 33002344 | Prognostic | Upregulated | Tissue | Stomach Cancer | Screening lncRNAs with diagnostic and prognostic value for human stomach |
ESM1 | 31882514 | Prognostic | Unknown | Tissue | Stomach Cancer | Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer |
ESM1 | 27644250 | Prognostic | Unknown | Other | Stomach Cancer | Endocan reduces the malign grade of gastric cancer cells by regulating associated |
ESM1 | 27340359 | Prognostic | Unknown | Tissue | Stomach Cancer | Endocan-expressing microvessel density as a prognostic factor for survival in |
ESM1 | 25056533 | Prognostic | Unknown | Blood | Stomach Cancer | Endothelial cell-specific molecule-1: a potential serum marker for gastric |
ESM1 | 25012244 | Prognostic | Unknown | Other | Stomach Cancer | Biological and clinical implications of endocan in gastric cancer. |
ESM1 | 20383661 | Prognostic | Unknown | Tissue | Stomach Cancer | Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer. |
ESM1 | 38714987 | Prognostic | Unknown | Other | Gastric Cancer | Comprehensive analysis of T-cell regulatory factors and tumor immune |
ESM1 | 33002344 | Prognostic | Upregulated | Tissue | Gastric Cancer | Screening lncRNAs with diagnostic and prognostic value for human stomach |
ESM1 | 31882514 | Prognostic | Unknown | Tissue | Gastric Cancer | Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer |
ESM1 | 29019897 | Prognostic | Unknown | Tissue | Gastric Cancer | Endocan expression is correlated with poor progression-free survival in patients |
ESM1 | 27644250 | Prognostic | Unknown | Other | Gastric Cancer | Endocan reduces the malign grade of gastric cancer cells by regulating associated |
ESM1 | 27340359 | Prognostic | Unknown | Tissue | Gastric Cancer | Endocan-expressing microvessel density as a prognostic factor for survival in |
ESM1 | 25056533 | Prognostic | Unknown | Blood | Gastric Cancer | Endothelial cell-specific molecule-1: a potential serum marker for gastric |
ESM1 | 25012244 | Prognostic | Unknown | Other | Gastric Cancer | Biological and clinical implications of endocan in gastric cancer. |
ESM1 | 38714987 | Prognostic | Unknown | Other | Cancer Related Stomach | Comprehensive analysis of T-cell regulatory factors and tumor immune |
ESM1 | 33002344 | Prognostic | Upregulated | Tissue | Cancer Related Stomach | Screening lncRNAs with diagnostic and prognostic value for human stomach |
ESM1 | 27644250 | Prognostic | Unknown | Other | Cancer Related Stomach | Endocan reduces the malign grade of gastric cancer cells by regulating associated |
ESM1 | 20383661 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer. |
PGM2L1 | 35966316 | Prognostic | Unknown | Other | Gastric Cancer | In silico development and validation of a novel glucose and lipid |
CST1 | 37996637 | Prognostic | Upregulated | Other | Stomach Cancer | Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for |
CST1 | 36383109 | Prognostic | Upregulated | Tissue | Stomach Cancer | Identifying Diagnostic and Prognostic Differentially Expressed Genes of Gastric |
CST1 | 34338150 | Prognostic | Unknown | Other | Stomach Cancer | Prognostic marker identification based on weighted gene co-expression network |
CST1 | 31115563 | Prognostic | Upregulated | Tissue | Stomach Cancer | HOXC10 overexpression promotes cell proliferation and migration in gastric |
CST1 | 37996637 | Prognostic | Upregulated | Other | Gastric Cancer | Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for |
CST1 | 36383109 | Prognostic | Upregulated | Tissue | Gastric Cancer | Identifying Diagnostic and Prognostic Differentially Expressed Genes of Gastric |
CST1 | 34338150 | Prognostic | Unknown | Other | Gastric Cancer | Prognostic marker identification based on weighted gene co-expression network |
CST1 | 31115563 | Prognostic | Upregulated | Tissue | Gastric Cancer | HOXC10 overexpression promotes cell proliferation and migration in gastric |
CST1 | 36383109 | Prognostic | Upregulated | Tissue | Cancer Related Stomach | Identifying Diagnostic and Prognostic Differentially Expressed Genes of Gastric |
CST1 | 34338150 | Prognostic | Unknown | Other | Cancer Related Stomach | Prognostic marker identification based on weighted gene co-expression network |
FOXS1 | 30918291 | Prognostic | Unknown | Tissue | Stomach Cancer | FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and |
FOXS1 | 30918291 | Prognostic | Unknown | Tissue | Gastric Cancer | FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and |
FOXS1 | 29088749 | Prognostic | Unknown | Other | Gastric Cancer | Identification and validation of a prognostic 9-genes expression signature for |
HOXC9 | 36749091 | Prognostic | Unknown | Other | Stomach Cancer | Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes |
HOXC9 | 32816159 | Prognostic | Unknown | Tissue | Stomach Cancer | HOXC9 overexpression is associated with gastric cancer progression and a |
HOXC9 | 36749091 | Prognostic | Unknown | Other | Gastric Cancer | Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes |
HOXC9 | 32816159 | Prognostic | Unknown | Tissue | Gastric Cancer | HOXC9 overexpression is associated with gastric cancer progression and a |
HOXC9 | 36749091 | Prognostic | Unknown | Other | Cancer Related Stomach | Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes |
HOXC9 | 32816159 | Prognostic | Unknown | Tissue | Cancer Related Stomach | HOXC9 overexpression is associated with gastric cancer progression and a |
HOXC10 | 37996637 | Prognostic | Upregulated | Other | Stomach Cancer | Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for |
HOXC10 | 36924407 | Prognostic | Unknown | Other | Stomach Cancer | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC10 | 36749091 | Prognostic | Unknown | Other | Stomach Cancer | Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes |
HOXC10 | 32356314 | Prognostic | Downregulated | Other | Stomach Cancer | MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to |
HOXC10 | 31115563 | Prognostic | Upregulated | Tissue | Stomach Cancer | HOXC10 overexpression promotes cell proliferation and migration in gastric |
HOXC10 | 30673899 | Prognostic | Unknown | Tissue | Stomach Cancer | Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines |
HOXC10 | 37996637 | Prognostic | Upregulated | Other | Gastric Cancer | Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for |
HOXC10 | 36924407 | Prognostic | Unknown | Other | Gastric Cancer | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC10 | 36749091 | Prognostic | Unknown | Other | Gastric Cancer | Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes |
HOXC10 | 32356314 | Prognostic | Downregulated | Other | Gastric Cancer | MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to |
HOXC10 | 36924407 | Prognostic | Unknown | Other | Cancer Related Stomach | HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an |
HOXC10 | 36749091 | Prognostic | Unknown | Other | Cancer Related Stomach | Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes |
HOXC10 | 32356314 | Prognostic | Downregulated | Other | Cancer Related Stomach | MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to |
HOXC10 | 29753747 | Prognostic | Upregulated | Tissue | Cancer Related Stomach | HOXC10 promotes gastric cancer cell invasion and migration via regulation of the |
BGN | 38041130 | Prognostic | Unknown | Other | Stomach Cancer | Identification of differentially expressed genes associated with the pathogenesis |
BGN | 38001949 | Prognostic | Unknown | Other | Stomach Cancer | Development of a Comprehensive Gene Signature Linking Hypoxia, Glycolysis, |
BGN | 36447214 | Prognostic | Unknown | Other | Stomach Cancer | Comprehensive analysis to identify pseudogenes/lncRNAs-hsa-miR-200b-3p-COL5A2 |
BGN | 36110576 | Prognostic | Unknown | Tissue | Stomach Cancer | Expression and the Prognostic Value of Biglycan in Gastric Cancer. |
BGN | 35325407 | Prognostic | Unknown | Other | Stomach Cancer | Bioinformatics Analysis and Identification of Potential Genes Associated with |
BGN | 38610959 | Prognostic | Unknown | Tissue | Gastric Cancer | Identification of Key Genes Associated with Tumor Microenvironment Infiltration |
BGN | 38041130 | Prognostic | Unknown | Other | Gastric Cancer | Identification of differentially expressed genes associated with the pathogenesis |
BGN | 38001949 | Prognostic | Unknown | Other | Gastric Cancer | Development of a Comprehensive Gene Signature Linking Hypoxia, Glycolysis, |
BGN | 36589754 | Prognostic | Unknown | Other | Gastric Cancer | Identification and validation of critical genes with prognostic value in gastric |
BGN | 36447214 | Prognostic | Unknown | Other | Gastric Cancer | Comprehensive analysis to identify pseudogenes/lncRNAs-hsa-miR-200b-3p-COL5A2 |
BGN | 36110576 | Prognostic | Unknown | Tissue | Gastric Cancer | Expression and the Prognostic Value of Biglycan in Gastric Cancer. |
BGN | 38001949 | Prognostic | Unknown | Other | Cancer Related Stomach | Development of a Comprehensive Gene Signature Linking Hypoxia, Glycolysis, |
BGN | 36447214 | Prognostic | Unknown | Other | Cancer Related Stomach | Comprehensive analysis to identify pseudogenes/lncRNAs-hsa-miR-200b-3p-COL5A2 |
BGN | 36110576 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Expression and the Prognostic Value of Biglycan in Gastric Cancer. |
BGN | 35325407 | Prognostic | Unknown | Other | Cancer Related Stomach | Bioinformatics Analysis and Identification of Potential Genes Associated with |
BGN | 34899080 | Prognostic | Unknown | Other | Cancer Related Stomach | Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs |
RAD51D | 34587437 | Prognostic | Unknown | Tissue | Gastric Cancer | Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human |
RAD51D | 32963463 | Prognostic | Unknown | Blood | Gastric Cancer | Characteristics of cancer susceptibility genes mutations in 282 patients with |
SLC39A10 | 37539127 | Prognostic | Unknown | Other | Gastric Cancer | Analysis and application of RNA binding protein gene pairs to predict the |
SLC39A10 | 30788004 | Prognostic | Upregulated | Tissue | Gastric Cancer | Analysis the prognostic values of solute carrier (SLC) family 39 genes in gastric |
TEAD4 | 35318441 | Prognostic | Unknown | Tissue | Stomach Cancer | USP49 mediates tumor progression and poor prognosis through a YAP1-dependent |
TEAD4 | 31924214 | Prognostic | Unknown | Tissue | Stomach Cancer | TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly |
TEAD4 | 35602596 | Prognostic | Unknown | Other | Gastric Cancer | TEAD4 as an Oncogene and a Mitochondrial Modulator. |
TEAD4 | 35318441 | Prognostic | Unknown | Tissue | Gastric Cancer | USP49 mediates tumor progression and poor prognosis through a YAP1-dependent |
TEAD4 | 31924214 | Prognostic | Unknown | Tissue | Cancer Related Stomach | TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly |
TEAD4 | 28759040 | Prognostic | Downregulated | Tissue | Cancer Related Stomach | TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric |
TIGD1 | 30548305 | Prognostic | Unknown | Tissue | Gastric Cancer | TIGD1, a gene of unknown function, involves cell-cycle progression and correlates |
TUBB3 | 35330576 | Prognostic | Unknown | Tissue | Stomach Cancer | [Immune-related genes and their determined immune cell microenvironment to |
TUBB3 | 32801780 | Prognostic | Unknown | Other | Stomach Cancer | The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach |
TUBB3 | 32522106 | Prognostic | Unknown | Other | Stomach Cancer | Association of high TUBB3 with resistance to adjuvant docetaxel-based |
TUBB3 | 30481034 | Prognostic | Unknown | Tissue | Stomach Cancer | Data-Independent Acquisition Mass Spectrometry To Quantify Protein Levels in FFPE |
TUBB3 | 24053422 | Prognostic | Unknown | Tissue | Stomach Cancer | Class III beta-tubulin is a predictive marker for taxane-based chemotherapy in |
TUBB3 | 23828702 | Prognostic | Unknown | Other | Stomach Cancer | [Effect of TUBB3, TS and ERCC1 mRNA expression on chemoresponse and clinical |
TUBB3 | 35330576 | Prognostic | Unknown | Tissue | Gastric Cancer | [Immune-related genes and their determined immune cell microenvironment to |
TUBB3 | 35174205 | Prognostic | Unknown | Tissue | Gastric Cancer | Establishment and Analysis of an Individualized Immune-Related Gene Signature for |
TUBB3 | 32522106 | Prognostic | Unknown | Other | Gastric Cancer | Association of high TUBB3 with resistance to adjuvant docetaxel-based |
TUBB3 | 30546449 | Prognostic | Upregulated | Tissue | Gastric Cancer | High expression of class III beta-tubulin in upper gastrointestinal cancer types. |
TUBB3 | 30481034 | Prognostic | Unknown | Tissue | Gastric Cancer | Data-Independent Acquisition Mass Spectrometry To Quantify Protein Levels in FFPE |
TUBB3 | 35330576 | Prognostic | Unknown | Tissue | Cancer Related Stomach | [Immune-related genes and their determined immune cell microenvironment to |
TUBB3 | 24053422 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Class III beta-tubulin is a predictive marker for taxane-based chemotherapy in |
TUBB3 | 22766748 | Prognostic | Unknown | Tissue | Cancer Related Stomach | Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with |